NCT03599479

Brief Summary

The aim of this study is to evaluate the efficacy of virtual reality experiences on acute pain and distress caused by fluoroscopic pain intervention in chronic pain patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

December 27, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2021

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

1.7 years

First QC Date

June 24, 2018

Last Update Submit

November 3, 2022

Conditions

Keywords

Virtual realityAcute painAnxiety

Outcome Measures

Primary Outcomes (1)

  • 11-point scale pain score

    11-point scale pain score was assessed by the patient during the fluoroscopic-guided intervention, 0-10. 0 means no pain, 10 means the most severe pain one can imagine

    15min after the procedure

Secondary Outcomes (9)

  • Hamilton Anxiety rating score (HAM-A)

    15min after the procedure

  • Net Promotor Score (NPS) by patient

    15min after the procedure

  • Net Promotor Score (NPS) by physician

    15min after the procedure

  • Total amount of local anesthetics used to skin infiltration

    intraoperative

  • Total procedural time

    intraoperative

  • +4 more secondary outcomes

Study Arms (2)

Virtual reality group

EXPERIMENTAL

* After experiencing the VR machine in the transfer bed for 5 minutes, the subject moves to the operating room. * After the subject moves to the surgical bed, he/she takes the appropriate position for the fluoroscopic pain intervention, and wears the virtual reality device (headset, headphone, smartphone). * After the subject starts the VR program, the practitioner starts the fluoroscopic pain intervention. * Lidocaine skin infiltration and description of the practitioner during the intervention are performed with the intervention when necessary.

Device: Virtual reality group

Conventional group

NO INTERVENTION

The fluoroscopic pain intervention is performed using only local anesthetics and description of the practitioner during the intervention as in the conventional cases.

Interventions

Virtual reality group The study intervention is to provide acute pain management for the subject undergoing fluoroscopic pain intervention by using the virtual reality program provided by the collaborator through virtual reality device (headset, headphone, and smartphone) that are commercialized on the market.

Also known as: Experimental
Virtual reality group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • If all of the following conditions are met :
  • Patient who has chronic pain lasting more than 3 months and whose pain doctor determined that he or she needs following fluoroscopic pain intervention : Lumbar sympathetic ganglion block (LSGB), Fluoroscopic-guided pulsed radiofrequency ablation (pRF), Fluoroscopic-guided radiofrequency thermocoagulation (hRF)
  • Adults who are at least 20 years of age
  • Patients whose American Society of Anesthesiologists(ASA) physical status is classified as 1 or 2.
  • A person who voluntarily agrees to participate in this clinical trial and has agreed in informed consent.

You may not qualify if:

  • If the subject falls under any of the following conditions :
  • Patients who cannot have virtual reality experience due to hearing or visual impairment
  • If the patient has difficulty communicating due to lack of cognitive ability
  • Patients that examiners deemed unsuitable for this trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (4)

  • Linton SJ. A review of psychological risk factors in back and neck pain. Spine (Phila Pa 1976). 2000 May 1;25(9):1148-56. doi: 10.1097/00007632-200005010-00017.

    PMID: 10788861BACKGROUND
  • Li A, Montano Z, Chen VJ, Gold JI. Virtual reality and pain management: current trends and future directions. Pain Manag. 2011 Mar;1(2):147-157. doi: 10.2217/pmt.10.15.

    PMID: 21779307BACKGROUND
  • Hoffman HG, Patterson DR, Seibel E, Soltani M, Jewett-Leahy L, Sharar SR. Virtual reality pain control during burn wound debridement in the hydrotank. Clin J Pain. 2008 May;24(4):299-304. doi: 10.1097/AJP.0b013e318164d2cc.

  • Nilsson S, Finnstrom B, Kokinsky E, Enskar K. The use of Virtual Reality for needle-related procedural pain and distress in children and adolescents in a paediatric oncology unit. Eur J Oncol Nurs. 2009 Apr;13(2):102-9. doi: 10.1016/j.ejon.2009.01.003. Epub 2009 Feb 20.

MeSH Terms

Conditions

Acute PainAnxiety Disorders

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Jee Youn Moon, MD, PhD

    Seoul National University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

June 24, 2018

First Posted

July 26, 2018

Study Start

December 27, 2018

Primary Completion

August 28, 2020

Study Completion

January 2, 2021

Last Updated

November 4, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations